Synergistic Anticancer Therapy by Ovalbumin Encapsulation-Enabled Tandem Reactive Oxygen Species Generation.
Fenton reactions
cisplatin
hypoxic
photodynamic therapy
synergistic
Journal
Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Titre abrégé: Angew Chem Int Ed Engl
Pays: Germany
ID NLM: 0370543
Informations de publication
Date de publication:
02 11 2020
02 11 2020
Historique:
received:
07
05
2020
revised:
16
06
2020
pubmed:
21
7
2020
medline:
30
3
2021
entrez:
21
7
2020
Statut:
ppublish
Résumé
The anticancer efficacy of photodynamic therapy (PDT) is limited due to the hypoxic features of solid tumors. We report synergistic PDT/chemotherapy with integrated tandem Fenton reactions mediated by ovalbumin encapsulation for improved in vivo anticancer therapy via an enhanced reactive oxygen species (ROS) generation mechanism. O
Identifiants
pubmed: 32686218
doi: 10.1002/anie.202006649
pmc: PMC7693068
doi:
Substances chimiques
Antineoplastic Agents
0
Photosensitizing Agents
0
Reactive Oxygen Species
0
Ovalbumin
9006-59-1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20008-20016Informations de copyright
© 2020 The Authors. Published by Wiley-VCH GmbH.
Références
Materials (Basel). 2015 Jul 20;8(7):4421-4456
pubmed: 28793448
Nat Commun. 2020 Apr 20;11(1):1857
pubmed: 32312987
Cancer Metastasis Rev. 2007 Jun;26(2):319-31
pubmed: 17458507
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
J Am Chem Soc. 2017 Jun 7;139(22):7595-7602
pubmed: 28459562
Nat Commun. 2015 Nov 03;6:8785
pubmed: 26525216
Angew Chem Int Ed Engl. 2017 Jul 17;56(30):8801-8804
pubmed: 28464414
Oncogenesis. 2018 Jan 24;7(1):10
pubmed: 29362402
Adv Mater. 2016 Sep;28(33):7129-36
pubmed: 27283434
ACS Nano. 2017 May 23;11(5):4463-4474
pubmed: 28362496
Angew Chem Int Ed Engl. 2016 Feb 24;55(9):3036-9
pubmed: 26804551
Adv Mater. 2018 Dec;30(52):e1802479
pubmed: 30387197
Biomaterials. 2019 Jun;206:170-182
pubmed: 30939409
Nano Lett. 2018 Dec 12;18(12):7609-7618
pubmed: 30383966
Adv Mater. 2016 Apr 13;28(14):2716-23
pubmed: 26848553
Leuk Lymphoma. 2015 Jan;56(1):26-33
pubmed: 24678978
Chem Rev. 2017 Nov 22;117(22):13566-13638
pubmed: 29048884
Acc Chem Res. 2020 Apr 21;53(4):752-762
pubmed: 32027481
Nat Commun. 2016 Aug 17;7:12499
pubmed: 27530650
J Am Chem Soc. 2018 Nov 7;140(44):14851-14859
pubmed: 30362735
Biomaterials. 2020 Mar;233:119755
pubmed: 31927233
Cancer Res. 2002 Jun 15;62(12):3387-94
pubmed: 12067980
Adv Mater. 2018 Jun;30(23):e1707509
pubmed: 29707841
Angew Chem Int Ed Engl. 2016 Mar 7;55(11):3606-10
pubmed: 26845734
Adv Mater. 2019 Mar;31(11):e1805955
pubmed: 30680816
Angew Chem Int Ed Engl. 2013 Sep 16;52(38):10107-11
pubmed: 23881773
Adv Sci (Weinh). 2017 Apr 10;4(8):1600540
pubmed: 28852616
J Am Chem Soc. 2019 Jan 23;141(3):1366-1372
pubmed: 30565924
Adv Healthc Mater. 2015 Oct 28;4(15):2247-59
pubmed: 26333115
Chem Sci. 2017 Oct 31;9(2):502-512
pubmed: 29619206
Angew Chem Int Ed Engl. 2020 Nov 2;59(45):20008-20016
pubmed: 32686218
Angew Chem Int Ed Engl. 2018 Sep 3;57(36):11522-11531
pubmed: 29808948
J Am Chem Soc. 2018 Nov 21;140(46):15820-15826
pubmed: 30380856
Adv Funct Mater. 2016 Mar 15;26(11):1757-1768
pubmed: 31749670
J Am Chem Soc. 2015 Feb 4;137(4):1539-47
pubmed: 25574812
Adv Mater. 2018 Mar;30(11):
pubmed: 29349918
Biomaterials. 2019 Oct;218:119330
pubmed: 31301577
Nano Lett. 2017 Feb 8;17(2):928-937
pubmed: 28139118
Angew Chem Int Ed Engl. 2020 Apr 27;59(18):7069-7075
pubmed: 32017379
Target Oncol. 2012 Dec;7(4):233-42
pubmed: 23054400
J Am Chem Soc. 2019 Feb 13;141(6):2695-2702
pubmed: 30652866
Drug Discov Today. 2013 Dec;18(23-24):1292-300
pubmed: 24055842